THE ADDITION OF BEVACIZUMAB IN THE TREATMENT OF PATIENTS WITH METASTASTIC CANCER, INCREASES THE INCIDENCE OF CARDIOVASCULAR EVENTS: A PROSPECTIVE STUDY

Archontoula Michelongona; Konstantinos Toutouzas; Andreas Synetos; Flora Zagouri; Aristotle Bamias; Meletios A Dimopoulos; Stella Kyvelou; Ioannis Kapelakis; Dimitris Tousoulis; Christodoulos Stefanadis

doi:10.1016/s0735-1097(12)60538-5

Related publications

Article2016

Bevacizumab increases the incidence of cardiovascular events in patients with metastatic breast or colorectal cancer

Ioannis Kapelakis, Konstantinos Toutouzas, Maria Drakopoulou, Archontoula Michelongona, Flora Zagouri, Aristotle Mpamias, Paraskevi Pliatsika, Meletios A Dimopoulos, Christodoulos Stefanadis, Dimitrios Tousoulis

Letter2011

Systemic administration of bevacizumab increases the risk of cardiovascular events in patients with metastatic cancer

Christodoulos Stefanadis, Andreas Synetos, Dimitris Tousoulis, Eleftherios Tsiamis, Archontoula Michelongona, Flora Zagouri, Aristotle Bamias, Meletios A Dimopoulos, Stella Kyvelou, Ioannis Kapelakis, Konstantinos Toutouzas

Article2019

Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort study

Watcharee Rungapiromnan, K.J. Mason, Mark Lunt, Kathleen McElhone, A. David Burden, Martin K. Rutter, Richard B. Warren, Christopher Em Griffiths, Darren M. Ashcroft

Article2009

The Addition of Bortezomib to the Combination of Lenalidomide and Dexamethasone Increases Bone Formation in Relapsed/Refractory Myeloma: a Prospective Study in 91 Patients.

Evangelos Terpos, Dimitrios Christoulas, Efstathios Kastritis, Μαρία Ρούσσου, Maria Gavriatopoulou, Magdalini Migkou, Μαρία Γκοτζαμανίδου, Marina Iakovaki, Αθανάσιος Παπαθεοδώρου, Meletios A Dimopoulos

Article2005

A Prospective Study on Cardiovascular Events After Acute Pulmonary Embolism

Cecilia Becattini, Giancarlo Agnelli, Paolo Prandoni